AllDocs -> heart diseases

COMPANY CONTACT: Cindy Presar, Investor Relations cpresar@cardiodynamics.com 800-778-4825 Ext. 1031 CardioDynamics Announces Publication of Multicenter Hypertension CONTROL Trial Published in Hypertension , an American Heart Association Journal SAN DIEGO—March 7, 2006--CardioDynamics (Nasdaq: CDIC), the innovator and leader of impedance cardiography (ICG) technology, today announced the publication of its multicenter, randomized trial called CONTROL (Consideration Of Noninvasive Hemodynamic Monitoring To Target Reduction Of Blood Pressure Levels). The article was published online in Hypertension , an American Heart Association journal, and the print version of the article will appear in the April edition of the journal. The study demonstrated that using the Company’s BioZ ® ICG to make drug decisions achieved 35% superiority in blood pressure control to ...

Topic: Renovascular Hypertension Hypertension affects an estimated 10 percent to 25 percent of the U.S. population. Of these, the great majority have primary elevation of blood pressure, which can be ameliorated with pharma- cological treatment. A subset of patients — an estimated 3 percent to 8 percent — have sec- ondary hypertension attributable to renovascular disease caused by narrowing of the renal artery. 1-2 Diminished perfusion to the kidney results in increased renin secretion and production of angiotensin II, leading to systemic vasoconstriction and retention of salt and water. Renovascular hyper- tension may be present when systemic blood pres- sure is normal. Renovascular hypertension has emerged as a major cause of end-stage renal disease, especially in the elderly. As the U.S. population ages, the num- ber of individuals with atherosclerotic ...

Communications and Public Information Telephone: National Center (317) 637-9200 ext.127 or 117 Fax (317) 634-7817 American College of Sports Medicine P.O. Box 1440 Indianapolis, IN 46206- 1440 MEMBER ALERT ACSM RELEASES EXERCISE AND HYPERTENSION POSITION STAND Exercise is a major lifestyle modification needed to prevent, treat, and control hypertension INDIANAPOLIS – Exercise is the cornerstone therapy for the primary prevention, treatment, and control of hypertension , according to the new Position Stand Exercise and Hypertension released today from the American College of Sports Medicine (ACSM). Adults w ith hypertension should seek to gain at least 30 minutes of moderate-intensity physical activity on most, if not all, days of the w eek, but they should be evaluated, treated, and ...

ESH Definition and Prevalence Hypertension is still a major health problem affect- ing approximately 30% of the population by the age of 60 years. 10% of the hypertensive patients appear resistant to therapy (1,2). Resistant hyper- tension is defined as failure of concomitant use of three or more different antihypertensive agents to lower blood pressure to less than 140/90 mmHg (3) in all age groups. Older studies estimated the preva- lence of refractory hypertension in tertiary care cen- ters to be between 5 and 18 % (4-9). In a large cohort study Alderman et al. found that only 2.9% were resistant to antihypertensive therapy (10). Recent clinical trials suggest that resistant hyper- tension is increasingly common. ALLHAT (Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack) Study results indicate a high- er prevalance. Among 14722 patients above 55 years, ...

Evidence Synthesis Number 34 Primary Care Screening for Ocular Hypertension and Primary Open-Angle Glaucoma: Evidence Synthesis Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-02-0024 Task Order No. 2 Technical Support of the U.S. Preventive Services Task Force Prepared by: Oregon Evidence-based Practice Center Portland, Oregon Craig Fleming, MD Evelyn Whitlock, MD, MPH Tracy Beil, MS Barbara Smit, MD, PhD March 2005 Page 2 iii Preface The Agency for Healthcare Research and Quality (AHRQ) sponsors the development of Systematic Evidence Reviews (SERs) and Evidence Syntheses through its Evidence-based Practice Program. With guidance ...

What you should know about hypertension The innovative Swiss pharmaceutical company Page 2 Blood pressure above 140/90 mm Hg is called hypertension Hypertension often does not cause any symptoms Everyone can develop hypertension independent of age and sex Hypertension can cause life- threatening events like heart attacks and strokes Hypertension should be treated Page 3 Patient Information “ Hypertension ” High blood pressure ( hypertension ) can be inherited to a certain extent. Aside from this predisposition the per- sonal lifestyle plays an important role. Everyone has it in the hand to play an active role in the prevention of hypertension and its life-threatening effects. Start today ...

doi:10.1136/bmj.328.7440.634 2004;328;634-640 BMJ McInnes, John F Potter, Peter S Sever and Simon McG Thom Bryan Williams, Neil R Poulter, Morris J Brown, Mark Davis, Gordon T summary hypertension management 2004 (BHS-IV): British Hypertension Society guidelines for http://bmj.com/cgi/content/full/328/7440/634 Updated information and services can be found at: These include: Data supplement http://bmj.com/cgi/content/full/328/7440/634/DC1 "Categories of strength used in statements" References http://bmj.com/cgi/content/full/328/7440/634#otherarticles 29 online articles that cite this article can be accessed at: http://bmj.com/cgi/content/full/328/7440/634#BIBL This article cites 22 articles, 7 of which can be accessed free at: Rapid responses http://bmj.com/cgi/eletter-submit/328/7440/634 ...

7 Pharmacologic Treatment of Hypertension T his chapter reviews the currently available classes of drugs used in the treatment of hypertension . To best appreciate the com- plexity of selecting an antihypertensive agent, an understanding of the pathophysiology of hypertension and the pharmacology of the various drug classes used to treat it is required. A thorough under- standing of these mechanisms is necessary to appreciate more fully the workings of specific antihypertensive agents. Among the factors that modulate high blood pressure, there is considerable overlap. The drug treatment of hypertension takes advantage of these integrated mecha- nisms to alter favorably the hemodynamic pattern associated with high blood pressure. Garry P. Reams John H. Bauer C H A P T E R Page 2 7.2 Hypertension ...

CARDIOVASCULAR WAIVERS CONDITION: HYPERTENSION (ICD9 401.9) AEROMEDICAL CONCERNS : Untreated hypertension is a major risk factor for the development of cardiovascular disease including coronary artery disease, congestive heart failure, cerebrovascular accidents, peripheral vascular disease, and renal disease. The relative risk of developing coronary artery disease is compounded when untreated hypertension co-exists with hyperlipidemia, cigarette smoking, increasing age, or diabetes. WAIVERS : Waivers for hypertension are routinely granted for Class 2, 3, & 4 aircrew members when treatment has achieved a normotensive state (less than 140/90 mm Hg) and evaluation reveals no underlying pathology. Individuals controlled with lifestyle modifications alone will also require a waiver even though control is achieved without medication. INFORMATION REQUIRED : The goal of initial work-up of a ...

AREA Male Female Male Female Male Female Male Female Male Female Male Female Male Female NUMBER RATE yrs. 5 - 14 15 - 49 50 - 64 65 yrs. NOTIFIABLE DISEASES: HYPERTENSION By Health Region, Province & City Philippines, 2002 By Age-Group and By Sex TOTAL BOTH SEXES 1 yr. yrs. TOTAL & above yrs. yrs. LESS THAN 1 - 4 PHILIPPINES 17 18 121 101 354 914 40,447 63,199 56,379 64,882 38,905 39,565 136,011 168,679 304,690 383.2 NAT. CAP. REGION 1 - 6 3 9 25 2,112 3,456 2,507 3,752 ...